Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Announces Planned Transition of Chief Financial Officer
Quanterix Appoints CFO Vandana Sriram Plans To Depart
TD Cowen Maintains Hold on Quanterix, Lowers Price Target to $4
Quanterix (QTRX) Q1 2026 Earnings Transcript
Quanterix Q1 Earnings Call Highlights
Quanterix Corporation 2026 Q1 - Results - Earnings Call Presentation
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates
Quanterix (NASDAQ:QTRX) Beats Q1 2026 EPS Estimates Despite Revenue Miss
Quanterix Releases Financial Results for the First Quarter of 2026
Quanterix Corporation (QTRX) Q1 2026 Earnings Call Transcript
Quanterix Affirms FY2026 Sales Guidance of $169.000M-$174.000M vs $170.887M Est
Quanterix Q1 EPS $(0.37) Beats $(0.45) Estimate, Sales $36.415M Miss $37.221M Estimate
Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026
Canaccord Genuity Maintains Hold on Quanterix, Lowers Price Target to $4
AidaBREAST™ Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology
PreludeDx, Quanterix Announce Development Of AidaBREAST On Akoya PhenoImager HT Platform Through Opal Chemistry
Quanterix Debuts Content Innovation Engine at AACR 2026
Quanterix: No Green Shoots
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.